Questions and Answers for New vaccine against influenza H1N1

Wednesday, August 26, 2009
Questions and Answers
New vaccine against influenza H1N1

Q. What are the plans for the development of H1N1 vaccine?

A. Vaccine are the most effective public health to combat influenza and the United States government is working closely with manufacturers to take steps in the production of a vaccine against H1N1. In collaboration with scientists from the public and private sectors, the CDC isolated the H1N1 virus new and modified so that it can be used by hundreds of millions of doses of vaccine. Manufacturers of vaccines are now made of these materials, the production of vaccines. Vaccine production is a multistage process that takes several months to complete. The vaccines were tested in clinical trials in recent months.

Q. When it is assumed that the new H1N1 vaccine is available available?

A. The novel H1N1 vaccine available this fall. More detailed data cannot at this point that the availability of vaccines depends on several factors, including the production and the time will be provided for the conduct of clinical trials



Q. Seasonal flu vaccine does not protect against avian influenza H1N1?

Q. The vaccine against seasonal influenza should not protect against novel avian influenza H1N1.

Vaccine given P. The novel H1N1 season and at the same time?

A. It hopes to have the H1N1 seasonal flu vaccines the same day. However, we expect the seasonal vaccine is available before the H1N1 vaccine. The normal seasonal influenza virus, are still waiting to cause illness in autumn and winter. Are invited to get their seasonal flu vaccine when they become available.

Q. Be invited to receive the priority categories of H1N1 vaccine?

A. CDC 's Advisory Committee on Immunization (ACIP) has recommended that certain group of people against the H1N1 vaccine is available, when he won. These population groups are pregnant women, people who live with care for children under 6 months of age, health and emergency medical personnel, persons aged 6 months to 24 years and 25 to 64, the highest risk of novel H1N1 due to chronic diseases and the immune system.

Should not be a shortage of vaccine H1N1, but supply and demand can be unpredictable. It is possible that the first vaccine will be available in limited quantities. In this context, the Committee recommended that the following sets of vaccine before others who are pregnant, people who live with, or care for children under 6 months of age, health services and emergency medical personnel in direct contact with patients, children between 6 months and 4 years and children 5 to 18 who have chronic illnesses.

The Committee has recognized the need to assess the supply and demand at local level. The Committee also recommended that when request arrives vaccines against these priority groups at the local level, programs and practitioners should begin to vaccinate all age groups between 25 and 64 years. Recent studies show that the risk of infection in people 65 and older is lower than the risk for younger age groups. Therefore, the vaccine supply and demand for the vaccine between younger age groups completed their programs and vaccination providers should offer more than 65 years.

Q. If the vaccine is available?


A. Each state is developing a plan for the management of vaccines. The vaccine is organized on a combination of guidelines, such as immunization clinics in local health departments, the offices of healthcare providers, schools and other private organizations such as pharmacies and workplaces.

Q. There are other ways to prevent the spread of the disease?

A. Activities of daily use to maintain their health.

Cover nose and mouth with a tissue when you sneeze or cough. Throw the tissue away after use.
Wash your hands often with soap and water, especially after coughing or sneezing. Alcohol-based hand cleaners are also effective.
Avoid touching your eyes, nose or mouth. The germs in this way.
Stay homes if sick. The CDC recommends staying home from work or school and limit contact with others that do not infect others.


Dissociate the effects of public health guidelines for closing schools, avoiding crowds and other social measures. These measure are still available after a H1N1 vaccine important, because the spread of other viruses can prevent infections cause respiratory irritation.

Q: What about the use of antiviral drugs for the treatment of H1N1 infections in the novel?

A. Antiviral drugs prescription drugs (pills, liquids or powders) are inhaled, which is the fight the flu virus from reproducing in the body. If you get sick, antivirals that your minor illnesses and make you feel better faster. It cans also prevent serious flu complications. This fall, antivirals may be a priority for people with serious illnesses or patients with an increased risk of complications of influenza.

Q. H1N1 is the influenza vaccination became mandatory?

A. The CDC and ACIP Advisory Committee (for vaccinations, advice and guidance on control of diseases preventable by vaccination) offers advise for those who receive the influenza H1N1, state and local health departments and determine how these recommendations apply. If the vaccine is advised to choose the vaccine) than for themselves or for their children screened for contraindications to vaccination (eg, allergy to eggs, and, provided information sheets describing the risks of the vaccine benefits, potential side effects associated with vaccination are linked, and show them how these events.

share on: facebook

Related Posts



0 comments:

Post a Comment